Covered recipient · General Payments record
NAIM ESSAM BIDEIWY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,460.37
- Reported across 39 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $683.13 | 10 |
| Education | $99.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $249.00 | 2 |
| GENZYME CORPORATION | $207.12 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $141.41 | 2 |
| GlaxoSmithKline, LLC. | $124.16 | 1 |
| ABBVIE INC. | $23.07 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $21.65 | 1 |
| Celgene Corporation | $15.72 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.07 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106525146 | CMS |
| Celgene Corporation | $15.72 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101141618 | CMS |
| GENZYME CORPORATION | $40.91 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139879385 | CMS |
| GENZYME CORPORATION | $18.06 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139879417 | CMS |
| GENZYME CORPORATION | $148.15 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139879479 | CMS |
| GlaxoSmithKline, LLC. | $124.16 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115863862 | CMS |
| Janssen Biotech, Inc. | $99.00 | 06/27/2024 | Education | Undisputed | 01/23/2026 | 1078447212 | CMS |
| Janssen Biotech, Inc. | $150.00 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078450843 | CMS |
| RECORDATI_RARE_DISEASES_INC. | $21.65 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139167845 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $22.68 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144972128 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $118.73 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144972130 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.